Variant report
Variant | esv3486654 |
---|---|
Chromosome Location | chr20:25679002-25682400 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:15)
- CpG islands (count:61)
- Chromatin interactive region (count:2)
- LncRNA region (count:2)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:15 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | ARID3A | chr20:25680595-25680824 | K562 | blood: | n/a | n/a |
2 | CEBPB | chr20:25680733-25680807 | A549 | lung: | n/a | n/a |
3 | CTCF | chr20:25680218-25680266 | Kidney_OC | kidney: | n/a | n/a |
4 | FOS | chr20:25680617-25680952 | MCF10A-Er-Src | breast: | n/a | n/a |
5 | FOS | chr20:25680665-25680937 | MCF10A-Er-Src | breast: | n/a | n/a |
6 | KAP1 | chr20:25680157-25681228 | K562 | blood: | n/a | n/a |
7 | MAFF | chr20:25680681-25680962 | HepG2 | liver: | n/a | chr20:25680794-25680812 |
8 | MAFF | chr20:25680627-25680929 | K562 | blood: | n/a | chr20:25680794-25680812 |
9 | MAFK | chr20:25680619-25680915 | K562 | blood: | n/a | n/a |
10 | MAFK | chr20:25680653-25680942 | HepG2 | liver: | n/a | n/a |
11 | MAFK | chr20:25680702-25680910 | HepG2 | liver: | n/a | n/a |
12 | POLR2A | chr20:25680783-25680828 | MCF10A-Er-Src | breast: | n/a | n/a |
13 | POLR2A | chr20:25680183-25680232 | MCF10A-Er-Src | breast: | n/a | n/a |
14 | SETDB1 | chr20:25680473-25681165 | U2OS | brain: | n/a | n/a |
15 | SREBP1 | chr20:25676527-25679236 | GM12878 | blood: | n/a | n/a |
No. | Chromosome Location | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr20:25681052-25681102 | HCPEpiC | choroid plexus: | n/a |
2 | chr20:25681052-25681102 | HMEC | breast: | n/a |
3 | chr20:25681052-25681102 | GM12878 | blood: | n/a |
4 | chr20:25681052-25681102 | AG04450 | lung: | fetal |
5 | chr20:25681052-25681102 | A549 | lung: | n/a |
6 | chr20:25681052-25681102 | SK-N-SH | brain: | n/a |
7 | chr20:25681052-25681102 | GM12891 | blood: | n/a |
8 | chr20:25681052-25681102 | SK-N-MC | brain: | n/a |
9 | chr20:25681052-25681102 | ProgFib | skin: | n/a |
10 | chr20:25681052-25681102 | LNCaP | prostate: | n/a |
11 | chr20:25681052-25681102 | Jurkat | blood: | n/a |
12 | chr20:25681052-25681102 | AG09319 | gingival: | n/a |
13 | chr20:25681052-25681102 | PFSK-1 | brain: | n/a |
14 | chr20:25681052-25681102 | GM19239 | blood: | n/a |
15 | chr20:25681052-25681102 | PANC-1 | pancreas: | n/a |
16 | chr20:25681052-25681102 | U87 | brain: | n/a |
17 | chr20:25681052-25681102 | NH-A | brain: | n/a |
18 | chr20:25681052-25681102 | H1-hESC | embryonic stem cell: | embryo |
19 | chr20:25681052-25681102 | HRCEpiC | kidney: | n/a |
20 | chr20:25681052-25681102 | CMK | blood: | n/a |
21 | chr20:25681052-25681102 | HRPEpiC | eye: | n/a |
22 | chr20:25681052-25681102 | NHDF-neo | bronchial: | n/a |
23 | chr20:25681052-25681102 | IMR90 | lung: | fetal |
24 | chr20:25681052-25681102 | HCT-116 | colon: | n/a |
25 | chr20:25681052-25681102 | T-47D | breast: | n/a |
26 | chr20:25681052-25681102 | ovcar-3 | ovarian: | n/a |
27 | chr20:25681052-25681102 | MCF-7 | breast: | n/a |
28 | chr20:25681052-25681102 | Hela-S3 | cervix: | n/a |
29 | chr20:25681052-25681102 | SAEC | small airway: | n/a |
30 | chr20:25681052-25681102 | HEEpiC | esophagus: | n/a |
31 | chr20:25681052-25681102 | HUVEC | blood vessel: | n/a |
32 | chr20:25681052-25681102 | HCM | heart: | n/a |
33 | chr20:25681052-25681102 | AoSMC | blood vessel: | n/a |
34 | chr20:25681052-25681102 | NHBE | bronchial: | n/a |
35 | chr20:25681052-25681102 | MCF10A-Er-Src | breast: | n/a |
36 | chr20:25681052-25681102 | Caco-2 | colon: | n/a |
37 | chr20:25681052-25681102 | K562 | blood: | n/a |
38 | chr20:25681052-25681102 | AG10803 | skin: | n/a |
39 | chr20:25681052-25681102 | HL-60 | blood: | n/a |
40 | chr20:25681052-25681102 | RPTEC | kidney: | n/a |
41 | chr20:25681052-25681102 | HCF | heart: | n/a |
42 | chr20:25681052-25681102 | GM06990 | blood: | n/a |
43 | chr20:25681052-25681102 | AG04449 | skin: | fetal |
44 | chr20:25681052-25681102 | AG09309 | skin: | n/a |
45 | chr20:25681052-25681102 | SK-N-SH_RA | brain: | n/a |
46 | chr20:25681052-25681102 | PrEC | prostate: | n/a |
47 | chr20:25681052-25681102 | HPAEpiC | pulmonary alveolar: | n/a |
48 | chr20:25681052-25681102 | HRE | kidney: | n/a |
49 | chr20:25681052-25681102 | NT2-D1 | testis: | n/a |
50 | chr20:25681052-25681102 | HEK293 | kidney: | embryo |
(count:2 , 50 per page) page:
1
(count:2 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-GINS1-6 | chr20:25679854-25679974 | NONHSAT079179 |
2 | lnc-GINS1-6 | chr20:25681199-25681397 | NONHSAT079179 |
No data |
No data |
Variant related genes | Relation type |
---|---|
ZNF337 | TF binding region |
ZNF337 | CpG island |
ENSG00000213742 | chromatin interactions |
ENSG00000170191 | chromatin interactions |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs373331171 | chr20:25679037-25679038 | Weak transcription Enhancers Active TSS | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
2 | rs181585726 | chr20:25679043-25679044 | Weak transcription Enhancers Active TSS | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
3 | rs552410130 | chr20:25679052-25679053 | Weak transcription Enhancers Active TSS | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
4 | rs562653493 | chr20:25679139-25679140 | Weak transcription Enhancers Active TSS | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
5 | rs13043042 | chr20:25679202-25679203 | Weak transcription Enhancers | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
6 | rs145846538 | chr20:25679209-25679210 | Weak transcription Enhancers | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
7 | rs186307837 | chr20:25679222-25679223 | Weak transcription Enhancers | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
8 | rs548492686 | chr20:25679231-25679232 | Weak transcription Enhancers | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
9 | rs568411075 | chr20:25679275-25679276 | Weak transcription Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
10 | rs548605228 | chr20:25679292-25679293 | Weak transcription Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
11 | rs533749612 | chr20:25679306-25679307 | Weak transcription Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
12 | rs144685936 | chr20:25679340-25679341 | Weak transcription Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
13 | rs147936216 | chr20:25679349-25679350 | Weak transcription Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
14 | rs113459695 | chr20:25679369-25679370 | Weak transcription Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
15 | rs188511054 | chr20:25679374-25679375 | Weak transcription Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
16 | rs141729893 | chr20:25679397-25679398 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs180885044 | chr20:25679415-25679416 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs538092954 | chr20:25679449-25679450 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs531245720 | chr20:25679490-25679491 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs114814498 | chr20:25679527-25679528 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs185199812 | chr20:25679547-25679548 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs150071856 | chr20:25679550-25679551 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs560507624 | chr20:25679572-25679573 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs191090329 | chr20:25679653-25679654 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs546238422 | chr20:25679655-25679656 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs530058947 | chr20:25679726-25679727 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs61052177 | chr20:25679762-25679763 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
28 | rs529667870 | chr20:25679812-25679813 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs531529887 | chr20:25679854-25679855 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
30 | rs549561447 | chr20:25679861-25679862 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
31 | rs114952960 | chr20:25679889-25679890 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
32 | rs369386824 | chr20:25679941-25679942 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
33 | rs567145753 | chr20:25679950-25679951 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
34 | rs183806721 | chr20:25679953-25679954 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
35 | rs373393627 | chr20:25679996-25679997 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs527549843 | chr20:25679998-25679999 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs187079876 | chr20:25679999-25680000 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs547735851 | chr20:25680035-25680036 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs73343258 | chr20:25680091-25680092 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
40 | rs376350424 | chr20:25680116-25680117 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs549842370 | chr20:25680144-25680145 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs73343264 | chr20:25680207-25680208 | Weak transcription | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
43 | rs79245872 | chr20:25680239-25680240 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
44 | rs554707168 | chr20:25680251-25680252 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
45 | rs4815446 | chr20:25680263-25680264 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
46 | rs149205698 | chr20:25680292-25680293 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
47 | rs191570338 | chr20:25680294-25680295 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
48 | rs4815447 | chr20:25680301-25680302 | Weak transcription | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
49 | rs143450284 | chr20:25680319-25680320 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
50 | rs137862867 | chr20:25680336-25680337 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Breast cancer | 16272173 | CNVD |
Melanoma | 18172304 | CNVD |
Cancer | 21637783 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Oral cancer | 19627613 | CNVD |
colon cancer | 17210682 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Cancer | 16751803 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Olfactory neuroblastoma | 18408657 | CNVD |
Central neurocytomas | 17123091 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Gastric cancer | 17908304 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Colorectal cancer | 21645411 | CNVD |
Lung cancer | 18438408 | CNVD |
Autism | 22495311 | CNVD |
Anaplastic large cell lymphoma | 18179710 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Cancer | 21183584 | CNVD |
Myxofibrosarcoma | 16751306 | CNVD |
Pancreatic endocrine tumor | 17639061 | CNVD |
Breast cancer | 16608533 | CNVD |
Bladder cancer | 21909424 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Mental retardation | 21062444 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Barrett''s adenocarcinoma | 18663352 | CNVD |
Chordoma | 18071362 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Breast cancer | 21364760 | CNVD |
Oral cancer | 21386901 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Schizophrenia | 23813976 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr20:25676600-25679200 | Active TSS | GM12878-XiMat | blood |
2 | chr20:25677800-25701000 | Weak transcription | Pancreas | Pancrea |
3 | chr20:25678000-25679600 | Enhancers | Primary T helper memory cells from peripheral blood 2 | blood |
4 | chr20:25678000-25679600 | Enhancers | Liver | Liver |
5 | chr20:25678000-25681600 | Weak transcription | Brain Hippocampus Middle | brain |
6 | chr20:25678000-25687600 | Weak transcription | Esophagus | oesophagus |
7 | chr20:25678400-25679200 | Enhancers | Fetal Brain Female | brain |
8 | chr20:25678400-25679200 | Enhancers | HepG2 | liver |
9 | chr20:25678800-25679200 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
10 | chr20:25678800-25680400 | Weak transcription | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
11 | chr20:25678800-25680400 | Weak transcription | Primary T helper cells PMA-I stimulated | -- |
12 | chr20:25679000-25680000 | Enhancers | Dnd41 | blood |
13 | chr20:25679000-25680600 | Weak transcription | Primary T helper memory cells from peripheral blood 1 | blood |
14 | chr20:25679200-25681200 | Weak transcription | Foreskin Melanocyte Primary Cells skin03 | Skin |
15 | chr20:25680000-25680400 | Weak transcription | Dnd41 | blood |
16 | chr20:25680400-25681000 | ZNF genes & repeats | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
17 | chr20:25680400-25681200 | ZNF genes & repeats | Primary T helper cells PMA-I stimulated | -- |
18 | chr20:25680400-25681400 | ZNF genes & repeats | Dnd41 | blood |
19 | chr20:25680600-25680800 | ZNF genes & repeats | Primary T helper memory cells from peripheral blood 1 | blood |
20 | chr20:25681000-25687600 | Weak transcription | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
21 | chr20:25681400-25687400 | Weak transcription | Dnd41 | blood |